Enriched circulating and tumor-resident TGF-β⁺ regulatory B cells in patients with melanoma promote FOXP3⁺ Tregs

Robert J Harrisa St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, Guy’s Hospital, London, UK;b King’s Health Partners Cancer Research UK Cancer Centre, King’s College London, London, UKView further author information

Zena Willsmorea St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, Guy’s Hospital, London, UK;b King’s Health Partners Cancer Research UK Cancer Centre, King’s College London, London, UKView further author information

Roman Laddacha St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, Guy’s Hospital, London, UK;c Department of Informatics, Faculty of Natural, Mathematical and Engineering Sciences, King’s College London, London, UKView further author information

Silvia Cresciolia St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, Guy’s Hospital, London, UKView further author information

Jitesh Chauhana St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, Guy’s Hospital, London, UKView further author information

Anthony Cheunga St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, Guy’s Hospital, London, UK;d Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King’s College London, Guy’s Hospital, London, UKView further author information

Anna Blacka St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, Guy’s Hospital, London, UKView further author information

Jenny L. C. Gehe Department of Plastic Surgery at Guy’s, King’s, and St. Thomas’ NHS Foundation Trust, London, UKView further author information

Alastair D MacKenzie Rosse Department of Plastic Surgery at Guy’s, King’s, and St. Thomas’ NHS Foundation Trust, London, UKView further author information

Ciaran Healye Department of Plastic Surgery at Guy’s, King’s, and St. Thomas’ NHS Foundation Trust, London, UKView further author information

Sophia Tsokac Department of Informatics, Faculty of Natural, Mathematical and Engineering Sciences, King’s College London, London, UKView further author information

James Spicerf School of Cancer & Pharmaceutical Sciences, King’s College London, Guy’s Hospital, London, UKView further author information

Katie E Lacya St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, Guy’s Hospital, London, UKView further author information

Sophia N Karagiannisa St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, Guy’s Hospital, London, UK;d Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King’s College London, Guy’s Hospital, London, UKCorrespondence[email protected]

https://orcid.org/0000-0002-4100-7810 View further author information

show all

Enriched circulating and tumor-resident TGF-β⁺ regulatory B cells in patients with melanoma promote FOXP3⁺ Tregs

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Enriched circulating and tumor-resident TGF-β+ regulatory B cells in patients with melanoma promote FOXP3+ Tregs

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Enriched circulating and tumor-resident TGF-β⁺ regulatory B cells in patients with melanoma promote FOXP3⁺ Tregs